ArticleJournal of hematology & oncology2014

XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).

Giovanni Luca Gravina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.